Bisecting GlcNAc is up-regulated in ovarian cancers, while treatment with 5-AZA of ovarian cancer cell lines induces MGAT3, bisecting GlcNAc expression [27], and changes in the pattern of glycosylation of secreted glycoproteins [28]. The gene discussed is MGAT3; the disease is ovarian carcinoma.